<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599812442867</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599812442867</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Head and Neck Surgery</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Removal of Biofilms from Tracheoesophageal Speech Valves Using a Novel Marine Microbial Deoxyribonuclease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Shakir</surname><given-names>Adam</given-names></name>
<degrees>MBChB, MRCS, DOHNS</degrees>
<xref ref-type="aff" rid="aff1-0194599812442867">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>ElBadawey</surname><given-names>Mohamed Reda</given-names></name>
<degrees>MSc, FRCS, MD</degrees>
<xref ref-type="aff" rid="aff2-0194599812442867">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Shields</surname><given-names>Robert Colquhoun</given-names></name>
<xref ref-type="aff" rid="aff3-0194599812442867">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jakubovics</surname><given-names>Nicholas Stephen</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff3-0194599812442867">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Burgess</surname><given-names>James Grant</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff4-0194599812442867">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599812442867"><label>1</label>James Cook University Hospital, Cleveland, UK</aff>
<aff id="aff2-0194599812442867"><label>2</label>Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK</aff>
<aff id="aff3-0194599812442867"><label>3</label>Centre for Oral Health Research, School of Dental Sciences, Newcastle University, Newcastle upon Tyne, UK</aff>
<aff id="aff4-0194599812442867"><label>4</label>Dove Marine Laboratory, School of Marine Science and Technology, Newcastle University, Newcastle upon Tyne, UK</aff>
<author-notes>
<corresp id="corresp1-0194599812442867">Mohamed Reda ElBadawey, MSc, FRCS, MD, Department of Otolaryngology and Head &amp; Neck Surgery, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust, Freeman Road, High Heaton, Newcastle upon Tyne, NE7 7DN, UK Email: <email>mohamed.reda@nuth.nhs.uk</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>147</volume>
<issue>3</issue>
<fpage>509</fpage>
<lpage>514</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>11</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>24</day>
<month>2</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>3</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0194599812442867">
<title>Objective</title>
<p>The growth of biofilms on tracheoesophageal speech valves shortens their life span and produces a reservoir of pathogens that may infect the respiratory tract. The authors have discovered a novel nontoxic deoxyribonuclease, NucB, from a marine isolate of <italic>Bacillus licheniformis</italic> that is effective at dispersing a variety of mono and mixed-species bacterial biofilms. The aim of this preliminary study was to determine whether NucB could also disrupt and remove mixed-species biofilms from tracheoesophageal speech valves.</p>
</sec>
<sec id="section2-0194599812442867">
<title>Study Design</title>
<p>Laboratory-based treatment and analysis of discarded tracheoesophageal speech valves.</p>
</sec>
<sec id="section3-0194599812442867">
<title>Setting</title>
<p>University human biology laboratory and the Department of Speech and Language Therapy at a tertiary referral hospital.</p>
</sec>
<sec id="section4-0194599812442867">
<title>Subjects and Methods</title>
<p>Seventeen ex vivo tracheoesophageal speech valves fouled with natural human biofilms were collected and divided into 2 equal parts. One half was treated with NucB and the other half with a control buffer solution. Biofilm removal was measured by microscopy and by culture of dispersed biofilm organisms on agar plates.</p>
</sec>
<sec id="section5-0194599812442867">
<title>Results</title>
<p>Significantly more organisms were released from biofilms using NucB than with buffer solution alone. On nonselective medium, more organisms were cultured in 11 samples (65%, n = 17, <italic>P</italic> &lt; .05). Using growth media favoring fungi, more organisms were cultured in 14 samples (82%, n = 17, <italic>P</italic> &lt; .05).</p>
</sec>
<sec id="section6-0194599812442867">
<title>Conclusion</title>
<p>The nontoxic deoxyribonuclease NucB was effective in releasing more microorganisms from biofilms on tracheoesophageal speech valves. This reflects its potential ability to break up and disperse these biofilms. Future studies will aim to develop NucB as a novel agent to prolong the life span of tracheoesophageal speech valves, thus reducing health care costs.</p>
</sec>
</abstract>
<kwd-group>
<kwd>prosthesis-related infections</kwd>
<kwd>microbiology</kwd>
<kwd>larynx artificial</kwd>
<kwd>laryngectomy</kwd>
<kwd>larynx microbiology</kwd>
<kwd>biofilms</kwd>
<kwd>prosthesis fitting</kwd>
<kwd>prosthesis adverse effects</kwd>
<kwd>laryngectomy rehabilitation</kwd>
<kwd>valve</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Atracheoesophageal speech valve (TESV) contains a 1-way valve that diverts the air in the trachea into the throat and mouth to enable phonation with the tongue and lips, without leakage of the saliva or food from the neopharynx into the airway. These valves are placed in a tracheoesophageal fistula that is surgically created to allow the passage of air into the upper esophagus and, subsequently, the oropharynx and oral cavity. In situ, silicone TESVs rapidly become colonized with bacteria and fungi, some of which are opportunistic pathogens.<sup><xref ref-type="bibr" rid="bibr1-0194599812442867">1</xref></sup> Soiling of the airway and respiratory tree leads to increased episodes of tracheal aspiration and tracheal irritation, leading to coughing.<sup><xref ref-type="bibr" rid="bibr2-0194599812442867">2</xref></sup> Another symptom that heralds the end of a TESV life is increased patient effort required to generate phonation, and subsequently speech becomes very disturbed.<sup><xref ref-type="bibr" rid="bibr3-0194599812442867">3</xref></sup> Furthermore, TESV failure impairs communication between the patient and his or her environment.<sup><xref ref-type="bibr" rid="bibr4-0194599812442867">4</xref></sup></p>
<p>The degradation of TESVs also leads to increased health care costs as valves have to be changed more frequently depending on the rate of colonization in a particular individual. In the Department of Otolaryngology, Freeman Hospital, Newcastle upon Tyne, UK, there were 64 patients on our records in 2010 who required TESVs. In the period from January 2010 to December 2010, 413 TESVs were used at a cost of $68,500 (excluding taxes and staff costs).</p>
<p>Cleaning of TESVs is particularly difficult because the micro-organisms that colonize them form biofilms.<sup><xref ref-type="bibr" rid="bibr1-0194599812442867">1</xref></sup> Standard current advice given to patients with regard to cleaning their TESV is to immerse it in warm water or to use baby bottle cleaning agents and gently mechanically clean the valve with a cotton bud or cleaning brush often supplied with the TESV. Some TESVs can be removed and cleaned intermittently. However, even frequent cleaning does not prolong the life of the device beyond approximately 3 to 5 months.<sup><xref ref-type="bibr" rid="bibr5-0194599812442867">5</xref></sup> At present, there are no mechanisms to clean permanently indwelling TESVs, and these devices are generally replaced every 2 to 3 months.</p>
<p>We have recently identified a novel biofilm-degrading enzyme, NucB, from the marine bacterium <italic>Bacillus licheniformis</italic> EI-34-6.<sup><xref ref-type="bibr" rid="bibr6-0194599812442867">6</xref></sup> In vitro, NucB could disperse biofilms produced by a different strain of <italic>Bacillus</italic> (<italic>B licheniformis</italic> DSM13) and by a range of medically relevant gram-positive and gram-negative organisms. NucB is a deoxyribonuclease specifically produced by <italic>B licheniformis</italic> when growing in biofilms. NucB targets extracellular DNA (eDNA), an important component of the biofilm matrix.</p>
<p>Treatment of young <italic>Pseudomonas aeruginosa</italic> biofilms with a commercially available nuclease, DNase I, resulted in dispersal of cells from the surfaces.<sup><xref ref-type="bibr" rid="bibr7-0194599812442867">7</xref></sup> It was also noticed that DNase I was more effective at releasing early <italic>P aeruginosa</italic> biofilms than at clearing established biofilms from surfaces.<sup><xref ref-type="bibr" rid="bibr7-0194599812442867">7</xref></sup> Therefore, the assessment of dispersed microbes using colony forming units (CFUs) could be an indirect method of assessing the effect of nuclease in dispersing at least the newly formed biofilms. Similarly, addition of DNase I to planktonic <italic>P aeruginosa</italic> cultures retarded the de novo formation of new biofilm.<sup><xref ref-type="bibr" rid="bibr7-0194599812442867">7</xref></sup></p>
<p><italic>Bacillus licheniformis</italic> NucB is smaller than DNase I and potentially may migrate through biofilms more efficiently. Concordantly, our preliminary in vitro studies indicate that NucB is more efficient than DNase I at removing biofilm.<sup><xref ref-type="bibr" rid="bibr6-0194599812442867">6</xref></sup></p>
<p>The aim of this preliminary study was to investigate the potential of the NucB enzyme to disperse natural mixed-species biofilms from TESVs. In the long term, the use of a nuclease in cleaning TESVs may make cleaning easier and prolong the lifetime of these devices.</p>
<sec id="section7-0194599812442867" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section8-0194599812442867">
<title>Study Design</title>
<p>This study was an anonymized primary research into the efficacy of NucB nuclease in a laboratory setting, with a case controlled design. We obtained the approval of the local National Health Service (NHS) Trust Research and Development (R&amp;D) Department to conduct this research, and it was confirmed that ethical approval was not required. The study was anonymous and did not involve any sampling of human tissue. No specific patient subgroup among TESV users was selected; valves were obtained on a “next-available” basis over a 4-month period.</p>
</sec>
<sec id="section9-0194599812442867">
<title>Specimens</title>
<p>Ex vivo TESVs (Blom-Singer, Forth Medical Ltd, Newbury, Berkshire, United Kingdom) that were due to be discarded were obtained from the hospital’s Speech and Language Therapy Department (Freeman Hospital, Newcastle Upon Tyne) and immediately placed in phosphate buffer solution (PBS) and stored at 4°C for up to 3 days before analysis.</p>
</sec>
<sec id="section10-0194599812442867">
<title>NucB Treatment of TESVs</title>
<p>Valves were divided into 2 equal parts along their longitudinal axes using a sterile scalpel (Swann-Morton, Sheffield, UK). There were 2 treatment arms. The active treatment used our agent, NucB DNase (3 µg/mL), in PBS at pH 7.3. The control treatment used PBS alone. Sterile polystyrene 12-well microtiter plates (Greiner Bio-One, Monroe, North Carolina) were used for the treatment of TESV halves. The half valves were each washed 3 times with sterile PBS and subsequently placed for 1 hour at 20°C either in a treatment well containing 500 µL NucB solution (3 µg/mL)<sup><xref ref-type="bibr" rid="bibr6-0194599812442867">6</xref></sup> and 2.5 mL sterile PBS solution or in a control well containing 3.0 mL sterile PBS.</p>
<p>Triplicate samples of the supernatant were diluted, and 50-µL aliquots were spread onto nutrient agar (Oxoid, Basingstoke, UK) or Sabouraud-dextrose agar (Oxoid). Plates were incubated for 16 to 20 hours at 37°C under aerobic conditions. Nutrient agar was chosen as a nonselective medium. Sabouraud-dextrose selects for fungi, including <italic>Candida</italic> spp. Following incubation of plates for 24 hours, colonies ≥2 mm were counted, and total colony-forming units (CFUs) released were calculated. Only plates with 10 to 400 colonies were counted. Representative colonies were picked, and strains were isolated by subculturing 3 times of solidified media. Isolates were analyzed by gram staining and microscopy. This method of detecting biofilm change was chosen over direct microscopy of valves before and after treatment, as the fixative process for scanning electron microscopy (SEM) destroys bacteria and alters the biofilm appearance by dehydration and the biofilm flora within.<sup><xref ref-type="bibr" rid="bibr8-0194599812442867">8</xref></sup> In addition, SEM can only demonstrate qualitatively the surface of the TESV or the biofilm upon it,<sup><xref ref-type="bibr" rid="bibr9-0194599812442867">9</xref></sup> making it hard to standardize the data. It is very difficult to locate 2 extremely similar biofilms, with reference to their thickness, amount of DNA present, and species composition, on the same valve.</p>
</sec>
<sec id="section11-0194599812442867">
<title>Statistical Analysis</title>
<p>Statistical analysis was performed on each TESV, comparing the triplicates from each half of the valve. Means derived from treatment and control CFU triplicate plate counts for each TESV half were used for the ratio of treatment and control values, standard error calculation, and χ<sup>2</sup> comparison testing. From this, <italic>P</italic> values and statistical significance (<italic>P</italic> &lt; .05) were derived.</p>
</sec>
</sec>
<sec id="section12-0194599812442867" sec-type="results">
<title>Results</title>
<p>As this was a laboratory study, no patients were affected. Twenty TESVs were obtained. The results of 3 TESVs were excluded from our study; 1 TESV culture solution did not produce any CFUs, and 2 TESV treatment and control solutions produced too many colonies to be counted accurately and were excluded. The results of the remaining 17 TESV culture plates were used for analysis.</p>
<p><xref ref-type="fig" rid="fig1-0194599812442867"><bold>Figure 1</bold></xref> represents the colonies grown from the supernatant from a valve. Half of the valve was treated with NucB nuclease and the other half with PBS alone. The NucB treatment clearly released more viable micro-organisms than PBS alone. These plates demonstrate that our novel NucB nuclease liberated more micro-organisms from TESV biofilms compared with the control treatment. This suggests that NucB nuclease has the potential to disrupt TESV biofilms. We hypothesize that the mechanism of action is by the degradation of eDNA, which holds the biofilm together, in the biofilm matrix on the TESV surface.</p>
<fig id="fig1-0194599812442867" position="float">
<label>Figure 1.</label>
<caption>
<p>Post 16-hour, 37°C incubation of nutrient agar plates. (A) Culture of the tracheoesophageal speech valve (TESV) bath containing NucB. (B) Control only.</p>
</caption>
<graphic xlink:href="10.1177_0194599812442867-fig1.tif"/>
</fig>
<p>From the CFU data, it was possible to determine which treatment generated higher CFU counts per valve. <xref ref-type="table" rid="table1-0194599812442867"><bold>Table 1</bold></xref> shows which treatment produced significantly higher CFU counts in all included valves. Higher CFU counts result from more micro-organisms being liberated from TESV surfaces. The active treatment with NucB generated higher CFU counts on both nutrient and Sabouraud agar, indicating that more micro-organisms and fungi, in particular, were released by treatment with NucB. <xref ref-type="table" rid="table2-0194599812442867"><bold>Table 2</bold></xref> shows the data from the 17 valves included in the study, confirming that more organisms were cultured in 11 samples (65%) on nonselective nutrient agar plates. The <italic>P</italic> values for each valve are included. <xref ref-type="table" rid="table3-0194599812442867"><bold>Table 3</bold></xref> shows the use of Sabouraud agar plates, favoring fungi, from all the included valves. It demonstrates that more organisms were cultured in 14 samples (82%). Treatment of TESVs with NucB released 5.7-fold more CFUs vs control (standard error [SE], 3.7-7.7) on selective Sabouraud agar and 5.0-fold more CFUs vs control on nonselective nutrient agar (SE, 3.1-6.9), as shown in <xref ref-type="fig" rid="fig2-0194599812442867"><bold>Figure 2</bold></xref>.</p>
<table-wrap id="table1-0194599812442867" position="float">
<label>Table 1.</label>
<caption>
<p>Summary of Which Treatment Generated Higher CFU Counts Cultured from Each TESV (n = 17)</p>
</caption>
<graphic alternate-form-of="table1-0194599812442867" xlink:href="10.1177_0194599812442867-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Active (NucB)</th>
<th align="center">Control (Phosphate Buffer Solution)</th>
<th align="center">Insignificant Difference</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nutrient agar</td>
<td>11<sup><xref ref-type="table-fn" rid="table-fn2-0194599812442867">a</xref></sup>
</td>
<td>1<sup><xref ref-type="table-fn" rid="table-fn2-0194599812442867">a</xref></sup>
</td>
<td>5</td>
</tr>
<tr>
<td>Sabouraud-dextrose agar</td>
<td>14<sup><xref ref-type="table-fn" rid="table-fn2-0194599812442867">a</xref></sup>
</td>
<td>2<sup><xref ref-type="table-fn" rid="table-fn2-0194599812442867">a</xref></sup>
</td>
<td>1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599812442867">
<p>Significance level was calculated by comparing the 2 halves of each valve. Abbreviations: CFU, colony-forming unit; TESV, tracheoesophageal speech valve.</p>
</fn>
<fn id="table-fn2-0194599812442867">
<label>a</label>
<p><italic>P</italic> &lt; .05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table2-0194599812442867" position="float">
<label>Table 2.</label>
<caption>
<p>Mean of Triplicate Plate CFU Count Using NucB Treatment and Control on Nutrient Agar</p>
</caption>
<graphic alternate-form-of="table2-0194599812442867" xlink:href="10.1177_0194599812442867-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Valve No.</th>
<th align="center">Treatment CFU</th>
<th align="center">Control CFU</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td> 1</td>
<td>10,230</td>
<td>2760</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td> 2</td>
<td>55,740</td>
<td>78,120</td>
<td>.<italic>0001</italic>
</td>
</tr>
<tr>
<td> 3</td>
<td>2520</td>
<td>600</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td> 4</td>
<td>21,960</td>
<td>21,840</td>
<td>.941</td>
</tr>
<tr>
<td> 5</td>
<td>2910</td>
<td>90</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td> 6</td>
<td>21,000</td>
<td>12,360</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td> 7</td>
<td>1890</td>
<td>300</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td> 8</td>
<td>1710</td>
<td>1110</td>
<td>.145</td>
</tr>
<tr>
<td>10</td>
<td>27,960</td>
<td>24,300</td>
<td><bold>.0387</bold></td>
</tr>
<tr>
<td>11</td>
<td>10,080</td>
<td>3930</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>12</td>
<td>6420</td>
<td>1470</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>14</td>
<td>9690</td>
<td>8850</td>
<td>.426</td>
</tr>
<tr>
<td>15</td>
<td>5922</td>
<td>582</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>16</td>
<td>28,020</td>
<td>20,760</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>17</td>
<td>3820</td>
<td>2640</td>
<td>.058</td>
</tr>
<tr>
<td>19</td>
<td>2400</td>
<td>200</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>20</td>
<td>15,400</td>
<td>15,040</td>
<td>.79</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0194599812442867">
<p>Note that valves 9, 13, and 18 were excluded. The bold <italic>P</italic> values show that NucB released more colony-forming units (CFUs), whereas the italic ones reflect valve solutions when the control produced more CFUs.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0194599812442867" position="float">
<label>Table 3.</label>
<caption>
<p>Mean of Triplicate Plate CFU Count Using NucB Treatment and Control on Sabouraud Agar</p>
</caption>
<graphic alternate-form-of="table3-0194599812442867" xlink:href="10.1177_0194599812442867-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Valve No.</th>
<th align="center">Treatment CFU</th>
<th align="center">Control CFU</th>
<th align="center"><italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>4410</td>
<td>12,120</td>
<td>.<italic>0001</italic>
</td>
</tr>
<tr>
<td>2</td>
<td>61,440</td>
<td>93,120</td>
<td>.<italic>0001</italic>
</td>
</tr>
<tr>
<td>3</td>
<td>2370</td>
<td>540</td>
<td><bold>.0005</bold></td>
</tr>
<tr>
<td>4</td>
<td>39,120</td>
<td>31,800</td>
<td><bold>.0038</bold></td>
</tr>
<tr>
<td>5</td>
<td>7470</td>
<td>600</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>6</td>
<td>12,360</td>
<td>8880</td>
<td><bold>.0021</bold></td>
</tr>
<tr>
<td>7</td>
<td>1380</td>
<td>150</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>8</td>
<td>2520</td>
<td>1710</td>
<td>.108</td>
</tr>
<tr>
<td>10</td>
<td>14,880</td>
<td>5910</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>11</td>
<td>5790</td>
<td>3510</td>
<td><bold>.0023</bold></td>
</tr>
<tr>
<td>12</td>
<td>2670</td>
<td>90</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>14</td>
<td>7530</td>
<td>4050</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>15</td>
<td>6900</td>
<td>480</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>16</td>
<td>30,480</td>
<td>21,600</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>17</td>
<td>5838</td>
<td>4122</td>
<td><bold>.0264</bold></td>
</tr>
<tr>
<td>19</td>
<td>2360</td>
<td>140</td>
<td><bold>.0001</bold></td>
</tr>
<tr>
<td>20</td>
<td>15,720</td>
<td>8960</td>
<td><bold>.0001</bold></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0194599812442867">
<p>Note that valves 9, 13, and 18 were excluded. The bold <italic>P</italic> values show that NucB released more colony-forming units (CFUs), whereas the italic ones reflect valve solutions when the control produced more CFUs.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig2-0194599812442867" position="float">
<label>Figure 2.</label>
<caption>
<p>The ratio of micro-organisms released by NucB compared with control. Standard error bars are shown. NucB is in gray and control in white. CFU, colony-forming unit.</p>
</caption>
<graphic xlink:href="10.1177_0194599812442867-fig2.tif"/>
</fig>
<p>Each valve yielded a variety of bacteria and fungi, and preliminary analysis using gram staining indicated the presence of gram-positive cocci and gram-negative rods. Tests identifying particular strains were not performed. Colony and organism morphology suggested a high prevalence of <italic>Candida</italic> spp. This is consistent with current literature.<sup><xref ref-type="bibr" rid="bibr10-0194599812442867">10</xref>,<xref ref-type="bibr" rid="bibr11-0194599812442867">11</xref></sup></p>
</sec>
<sec id="section13-0194599812442867" sec-type="discussion">
<title>Discussion</title>
<p>The aim of this study was to determine the ability of an eDNA degrading nuclease NucB to disrupt and remove mixed-organism biofilms from TESVs. The application of NucB to fouled TESVs resulted in significantly higher numbers of micro-organisms being released from the TESV surfaces compared with the control. NucB was effective at releasing organisms from the majority of the 17 TESVs analyzed (<italic>P</italic> &lt; .05 in 11 of 17 nutrient agar plates). The benefits of NucB were similar when Sabouraud-dextrose agar (selective for fungi, <italic>P</italic> &lt; .05 in 14 of 17 plates) was used, illustrating a general applicability of this method on mixed-species biofilms.</p>
<p>It is well known that micro-organisms in biofilms are protected against antimicrobials and other external stresses. For example, the control of <italic>Candida albicans</italic> biofilm requires approximately 4 times higher concentrations of fluconazole than are needed to eliminate planktonic (free-floating) cells.<sup><xref ref-type="bibr" rid="bibr12-0194599812442867">12</xref></sup> Long-term treatment with antifungals is undesirable as it encourages selection of resistant strains.<sup><xref ref-type="bibr" rid="bibr13-0194599812442867">13</xref></sup></p>
<p>Biofilms protect bacteria and fungi from antimicrobial agents by several mechanisms, including reduced penetration of antimicrobial agents into the cell colonies, slow growth of micro-organisms in biofilms,<sup><xref ref-type="bibr" rid="bibr14-0194599812442867">14</xref></sup> the presence of highly resistant “persister” cell types in biofilms,<sup><xref ref-type="bibr" rid="bibr15-0194599812442867">15</xref>,<xref ref-type="bibr" rid="bibr16-0194599812442867">16</xref></sup> and the upregulation of specific antimicrobial genes, such as those encoding efflux pumps<sup><xref ref-type="bibr" rid="bibr17-0194599812442867">17</xref></sup> in biofilms. A key component of biofilms is the extracellular matrix, which glues micro-organisms to the surface and provides a barrier to mass transfer of antimicrobial agents. There is now evidence that some bacteria in biofilms produce biofilm-degrading enzymes to enable the liberation of bacterial cells to new sites in a host in vivo. These same enzymes have been employed to disperse bacterial biofilms to good effect.<sup><xref ref-type="bibr" rid="bibr18-0194599812442867">18</xref></sup></p>
<p>The antibiofilm properties of the <italic>B licheniformis</italic> NucB enzyme were reported for biofilms formed by a variety of aerobic bacteria in model monospecies cultures.<sup><xref ref-type="bibr" rid="bibr6-0194599812442867">6</xref></sup> The current work demonstrates that NucB is also effective against natural mixed-species biofilms on TESVs. Of particular note is the observation that <italic>Candida</italic> spp. were released from biofilms by NucB. <italic>Candida</italic> spp. are common colonizers of TESV surfaces. In one study, the total <italic>Candida</italic> spp. cultures constituted more than 50% of organisms grown from TESVs at both the tracheal and esophageal surfaces of valves.<sup><xref ref-type="bibr" rid="bibr19-0194599812442867">19</xref></sup> It is noteworthy that <italic>Candida</italic> spp. have previously been shown to employ eDNA to stabilize their biofilms, and treatment with DNase I promotes biofilm removal.<sup><xref ref-type="bibr" rid="bibr20-0194599812442867">20</xref></sup> The eDNA therefore is an important component of mixed microbial biofilms and is produced in different ways: by cell lysis,<sup><xref ref-type="bibr" rid="bibr21-0194599812442867">21</xref></sup> autolysis-dependent cell lysis,<sup><xref ref-type="bibr" rid="bibr22-0194599812442867">22</xref></sup> or active excretion of eDNA from cells, for example, in vesicles.<sup><xref ref-type="bibr" rid="bibr23-0194599812442867">23</xref></sup> The eDNA is an important factor in the life span of the biofilm, notably as a microbial aggregator<sup><xref ref-type="bibr" rid="bibr24-0194599812442867">24</xref></sup> or as an important molecule in biofilm stability.<sup><xref ref-type="bibr" rid="bibr25-0194599812442867">25</xref></sup></p>
<p>An additional factor influencing the stability of biofilms is the composition of micro-organisms within them. The presence of <italic>Candida</italic> spp. has been demonstrated to encourage the attachment of <italic>Streptococcus gordonii</italic> and the development of mixed-species biofilm communities in the oral cavity.<sup><xref ref-type="bibr" rid="bibr26-0194599812442867">26</xref></sup> This study has shown a link between the behavior of <italic>Candida</italic> spp. and bacteria, and similar interactions may also occur on prosthetic TESV surfaces.<sup><xref ref-type="bibr" rid="bibr10-0194599812442867">10</xref></sup></p>
<p>The use of biosurfactants to treat TESV biofilms has been investigated; TESV biofilms were treated with a solution extracted from cultured <italic>Streptococcus thermophilus</italic>, but the active compound was not described.<sup><xref ref-type="bibr" rid="bibr27-0194599812442867">27</xref></sup> Another study used an active antibiofilm enzyme that was tested by measuring the altered surface tension of water droplets, although not against prosthetic surfaces.<sup><xref ref-type="bibr" rid="bibr28-0194599812442867">28</xref></sup> The study presented here is the first example of a bacterial nuclease being used to remove multispecies biofilms from TESVs.</p>
<p>This study used the method of micro-organism culture and the counting of CFUs to measure degradation of TESV biofilms as it was a rapid and sensitive method for detecting biofilm breakdown. The results indicated that NucB is an extremely promising agent for the control of biofilms on TESVs. This is an indirect measure of the ability of NucB to disrupt the biofilms. However, a great deal of further work is required to develop this enzyme as a useful adjunct to current cleaning protocols for TESVs. Therefore, further studies will aim to develop treatment protocols that can be used by patients for maintaining biofilm-free TESVs. The future studies will aim at the direct examination of the TESVs to evaluate the effectiveness of NucB in preventing and disrupting biofilms. It is hoped that such treatments will prolong the life span of TESVs and reduce the risks of TESV-related infections.</p>
<p>Microbial degradation of TESVs has been clearly demonstrated by scanning electron microscopy.<sup><xref ref-type="bibr" rid="bibr9-0194599812442867">9</xref></sup> Scanning electron microscopy has also been employed to study the microbial composition of TESV biofilms and has revealed that biofilms contain mixed populations of yeasts and bacteria.<sup><xref ref-type="bibr" rid="bibr9-0194599812442867">9</xref>,<xref ref-type="bibr" rid="bibr11-0194599812442867">11</xref></sup> Using confocal laser scanning microscopy (CLSM), we detected both bacteria and fungi in mixed-species biofilms on TESVs (data not shown), which is fully consistent with both the SEM studies and the CLSM analyses published by other groups.<sup><xref ref-type="bibr" rid="bibr10-0194599812442867">10</xref>,<xref ref-type="bibr" rid="bibr29-0194599812442867">29</xref></sup> Previous studies have documented reproducible spatial variations within TESV biofilms—for example, <italic>Candida</italic> spp. may be found deeper and adjacent to the silicone surface.<sup><xref ref-type="bibr" rid="bibr10-0194599812442867">10</xref></sup></p>
<p>In summary, this preliminary study has demonstrated that the use of the nuclease enzyme, NucB, from a marine bacterium, can release more microorganisms from biofilms found on TESVs in a statistically significant manner. This suggests its ability to disrupt biofilms on TESVs. This biofilm-degrading enzyme therefore has potential in the treatment and maintenance of TESVs, either as a sole treatment agent or in combination with other substances, to prolong the life span of TESVs.</p>
</sec>
<sec id="section14-0194599812442867">
<title>Author Contributions</title>
<p><bold>Adam Shakir</bold>, literature search, collection of samples, helping in the laboratory work, analysis of data, writing and revising the article; <bold>Mohamed Reda ElBadawey</bold>, conception and design, literature search, collection of samples, analysis of data, writing and revising the article; <bold>Robert Colquhoun Shields</bold>, literature search, collection of samples, performing the laboratory work, analysis of data, collection of samples, writing and revising the article; <bold>Nicholas Stephen Jakubovics</bold>, conception and design, literature search, collection of samples, analysis of data, writing and revising the article; <bold>James Grant Burgess</bold>, conception and design, literature search, collection of samples, analysis of data, writing and revising the article.</p>
</sec>
<sec id="section15-0194599812442867">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> Natural Environment Research Council for financial support through a follow-on fund award. We confirm that this funding source did not influence any part of our study or the writing of the manuscript. The funds were used to provide the consumables.</p>
</sec>
</body>
<back>
<ack>
<p>We thank Sarah Owen, Senior Speech &amp; Language Therapist, Freeman Hospital, Newcastle upon Tyne, UK, for the supply of used TESVs.</p>
</ack>
<fn-group>
<fn fn-type="presented-at">
<p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p>
<p>This article was presented at the 2011 AAO-HNSF Annual Meeting &amp; OTO EXPO; September 11-14, 2011; San Francisco, California.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599812442867">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bauters</surname><given-names>TGM</given-names></name>
<name><surname>Moerman</surname><given-names>M</given-names></name>
<name><surname>Vermeersch</surname><given-names>H</given-names></name>
<name><surname>Nelis</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Colonization of voice prostheses by <italic>Albicans</italic> and non-<italic>Albicans candida</italic> species</article-title>. <source>Laryngoscope</source>. <year>2002</year>;<volume>112</volume>(<issue>4</issue>):<fpage>708</fpage>-<lpage>712</lpage>.</citation>
</ref>
<ref id="bibr2-0194599812442867">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Acton</surname><given-names>LM</given-names></name>
<name><surname>Ross</surname><given-names>DA</given-names></name>
<name><surname>Sasaki</surname><given-names>CT</given-names></name>
<name><surname>Leder</surname><given-names>SB</given-names></name>
</person-group>. <article-title>Investigation of tracheoesophageal voice prosthesis leakage patterns: patient’s self-report versus clinician’s confirmation</article-title>. <source>Head Neck</source>. <year>2008</year>;<volume>30</volume>:<fpage>618</fpage>-<lpage>621</lpage>.</citation>
</ref>
<ref id="bibr3-0194599812442867">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Elving</surname><given-names>G</given-names></name>
<name><surname>van der Mei</surname><given-names>H</given-names></name>
<name><surname>Busscher</surname><given-names>H</given-names></name>
<name><surname>van Weissenbruch</surname><given-names>R</given-names></name>
<name><surname>Albers</surname><given-names>F</given-names></name>
</person-group>. <article-title>Influence of different combinations of bacteria and yeasts in voice prosthesis biofilms on air flow resistance</article-title>. <source>Antonie Van Leeuwenhoek</source>. <year>2003</year>;<volume>83</volume>(<issue>1</issue>):<fpage>45</fpage>-<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr4-0194599812442867">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Perry</surname><given-names>A</given-names></name>
</person-group>. <article-title>The role of the speech and language therapist in voice restoration after laryngectomy</article-title>. <source>J Laryngol Otol</source>. <year>1997</year>;<volume>111</volume>(<issue>1</issue>):<fpage>4</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr5-0194599812442867">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Den Hoogen</surname><given-names>FJA Van</given-names></name>
<name><surname>Oudes</surname><given-names>MJ</given-names></name>
<name><surname>Hombergen</surname><given-names>G</given-names></name>
<name><surname>Nijdam</surname><given-names>HF</given-names></name>
<name><surname>Manni</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>The Groningen, Nijdam and Provox voice prostheses: a prospective clinical comparison based on 845 replacements</article-title>. <source>Acta Otolaryngol</source>. <year>1996</year>;<volume>116</volume>(<issue>1</issue>):<fpage>119</fpage>-<lpage>124</lpage>.</citation>
</ref>
<ref id="bibr6-0194599812442867">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nijland</surname><given-names>R</given-names></name>
<name><surname>Hall</surname><given-names>MJ</given-names></name>
<name><surname>Burgess</surname><given-names>JG</given-names></name>
</person-group>. <article-title>Dispersal of biofilms by secreted, matrix degrading, bacterial DNase</article-title>. <source>PLoS ONE</source>. <year>2010</year>;<volume>5</volume>(<issue>12</issue>):<fpage>e15668</fpage>.</citation>
</ref>
<ref id="bibr7-0194599812442867">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Whitchurch</surname><given-names>CB</given-names></name>
<name><surname>Tolker-Nielsen</surname><given-names>T</given-names></name>
<name><surname>Ragas</surname><given-names>PC</given-names></name>
<name><surname>Mattick</surname><given-names>JS</given-names></name>
</person-group>. <article-title>Extracellular DNA required for bacterial biofilm formation</article-title>. <source>Science</source>. <year>2002</year>;<volume>295</volume>(<issue>5559</issue>):<year>1487</year>.</citation>
</ref>
<ref id="bibr8-0194599812442867">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Akiyama</surname><given-names>H</given-names></name>
<name><surname>Huh</surname><given-names>WK</given-names></name>
<name><surname>Yamasaki</surname><given-names>O</given-names></name>
<name><surname>Oono</surname><given-names>T</given-names></name>
<name><surname>Iwatsuki</surname><given-names>K</given-names></name>
</person-group>. <article-title>Confocal laser scanning microscopic observation of glycocalyx production by <italic>Staphylococcus aureus</italic> in mouse skin: does <italic>S. aureus</italic> generally produce a biofilm on damaged skin?</article-title> <source>Br J Dermatol</source>. <year>2002</year>;<volume>147</volume>:<fpage>879</fpage>-<lpage>885</lpage>.</citation>
</ref>
<ref id="bibr9-0194599812442867">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Neu</surname><given-names>TR</given-names></name>
<name><surname>der Mei</surname><given-names>HC</given-names></name>
<name><surname>Busscher</surname><given-names>HJ</given-names></name>
<name><surname>Dijk</surname><given-names>F</given-names></name>
<name><surname>Verkerke</surname><given-names>GJ</given-names></name>
</person-group>. <article-title>Biodeterioration of medical-grade silicone rubber used for voice prostheses: a SEM study</article-title>. <source>Biomaterials</source>. <year>1993</year>;<volume>14</volume>(<issue>6</issue>):<fpage>459</fpage>-<lpage>464</lpage>.</citation>
</ref>
<ref id="bibr10-0194599812442867">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buijssen</surname><given-names>KJDA</given-names></name>
<name><surname>van der Laan</surname><given-names>BFAM</given-names></name>
<name><surname>van der Mei</surname><given-names>HC</given-names></name>
<etal/>
</person-group>. <article-title>Composition and architecture of biofilms on used voice prostheses</article-title>. <source>Head Neck</source>. <year>2011</year> <month>Sep</month> <day>22</day> [<comment>Epub ahead of print</comment>]. doi:10.1002/hed.21833<pub-id pub-id-type="doi">10.1002/hed.21833</pub-id>.</citation>
</ref>
<ref id="bibr11-0194599812442867">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Neu</surname><given-names>TR</given-names></name>
<name><surname>Verkerke</surname><given-names>GJ</given-names></name>
<name><surname>Herrmann</surname><given-names>IF</given-names></name>
<name><surname>Schutte</surname><given-names>HK</given-names></name>
<name><surname>van der Mei</surname><given-names>HC</given-names></name>
<name><surname>Busscher</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Microflora on explanted silicone rubber voice prostheses: taxonomy, hydrophobicity and electrophoretic mobility</article-title>. <source>J Appl Microb</source>. <year>1994</year>;<volume>76</volume>(<issue>5</issue>):<fpage>521</fpage>-<lpage>528</lpage>.</citation>
</ref>
<ref id="bibr12-0194599812442867">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hawser</surname><given-names>SP</given-names></name>
<name><surname>Douglas</surname><given-names>LJ</given-names></name>
</person-group>. <article-title>Resistance of <italic>Candida albicans</italic> biofilms to antifungal agents in vitro</article-title>. <source>Antimicrob Agents Chemother</source>. <year>1995</year>;<volume>39</volume>(<issue>9</issue>):<fpage>2128</fpage>-<lpage>2131</lpage>.</citation>
</ref>
<ref id="bibr13-0194599812442867">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Elving</surname><given-names>GJ</given-names></name>
<name><surname>van der Mei</surname><given-names>HC</given-names></name>
<name><surname>van Weissenbruch</surname><given-names>R</given-names></name>
<name><surname>Albers</surname><given-names>FWJ</given-names></name>
<name><surname>Busscher</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Effect of antifungal agents on indwelling voice prosthetic biofilms</article-title>. <source>Curr Opin Otolaryngol</source>. <year>2000</year>;<volume>8</volume>(<issue>3</issue>):<fpage>165</fpage>-<lpage>168</lpage>.</citation>
</ref>
<ref id="bibr14-0194599812442867">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Walters</surname><given-names>MC</given-names><suffix>III</suffix></name>
<name><surname>Roe</surname><given-names>F</given-names></name>
<name><surname>Bugnicourt</surname><given-names>A</given-names></name>
<name><surname>Franklin</surname><given-names>MJ</given-names></name>
<name><surname>Stewart</surname><given-names>PS</given-names></name>
</person-group>. <article-title>Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of <italic>Pseudomonas aeruginosa</italic> biofilms to ciprofloxacin and tobramycin</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2003</year>;<volume>47</volume>(<issue>1</issue>):<fpage>317</fpage>-<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr15-0194599812442867">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brooun</surname><given-names>A</given-names></name>
<name><surname>Liu</surname><given-names>S</given-names></name>
<name><surname>Lewis</surname><given-names>K</given-names></name>
</person-group>. <article-title>A dose-response study of antibiotic resistance in <italic>Pseudomonas aeruginosa</italic> biofilms</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2000</year>;<volume>44</volume>(<issue>3</issue>):<fpage>640</fpage>-<lpage>646</lpage>.</citation>
</ref>
<ref id="bibr16-0194599812442867">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lewis</surname><given-names>K</given-names></name>
</person-group>. <article-title>Multidrug tolerance of biofilms and persister cells</article-title>. <source>Curr Top Microbiol Immunol</source>. <year>2008</year>;<volume>322</volume>:<fpage>107</fpage>-<lpage>131</lpage>.</citation>
</ref>
<ref id="bibr17-0194599812442867">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stover</surname><given-names>CK</given-names></name>
<name><surname>Pham</surname><given-names>XQ</given-names></name>
<name><surname>Erwin</surname><given-names>AL</given-names></name>
<etal/>
</person-group>. <article-title>Complete genome sequence of <italic>Pseudomonas aeruginosa</italic> PAO1, an opportunistic pathogen</article-title>. <source>Nature</source>. <year>2000</year>;<volume>406</volume>(<issue>6799</issue>):<fpage>959</fpage>-<lpage>964</lpage>.</citation>
</ref>
<ref id="bibr18-0194599812442867">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaplan</surname><given-names>JB</given-names></name>
</person-group>. <article-title>Biofilm dispersal: mechanisms, clinical implications, and potential therapeutic uses</article-title>. <source>J Dent Res</source>. <year>2010</year>;<volume>89</volume>(<issue>3</issue>):<fpage>205</fpage>-<lpage>218</lpage>.</citation>
</ref>
<ref id="bibr19-0194599812442867">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Weissenbruch</surname><given-names>R</given-names></name>
<name><surname>Albers</surname><given-names>FWJ</given-names></name>
<name><surname>Bouckaert</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Deterioration of the Provox silicone tracheoesophageal voice prosthesis: microbial aspects and structural changes</article-title>. <source>Acta Otolaryngol</source>. <year>1997</year>;<volume>117</volume>(<issue>3</issue>):<fpage>452</fpage>-<lpage>458</lpage>.</citation>
</ref>
<ref id="bibr20-0194599812442867">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martins</surname><given-names>M</given-names></name>
<name><surname>Uppuluri</surname><given-names>P</given-names></name>
<name><surname>Thomas</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Presence of extracellular DNA in the <italic>Candida albicans</italic> biofilm matrix and its contribution to biofilms</article-title>. <source>Mycopathologia</source>. <year>2010</year>;<volume>169</volume>(<issue>5</issue>):<fpage>323</fpage>-<lpage>331</lpage>.</citation>
</ref>
<ref id="bibr21-0194599812442867">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Webb</surname><given-names>JS</given-names></name>
<name><surname>Thompson</surname><given-names>LS</given-names></name>
<name><surname>James</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Cell death in <italic>Pseudomonas aeruginosa</italic> biofilm development</article-title>. <source>J Bacteriol</source>. <year>2003</year>;<volume>185</volume>(<issue>15</issue>):<fpage>4585</fpage>-<lpage>4592</lpage>.</citation>
</ref>
<ref id="bibr22-0194599812442867">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thomas</surname><given-names>VC</given-names></name>
<name><surname>Thurlow</surname><given-names>LR</given-names></name>
<name><surname>Boyle</surname><given-names>D</given-names></name>
<name><surname>Hancock</surname><given-names>LE</given-names></name>
</person-group>. <article-title>Regulation of autolysis-dependent extracellular DNA release by <italic>Enterococcus faecalis</italic> extracellular proteases influences biofilm development</article-title>. <source>J Bacteriol</source>. <year>2008</year>;<volume>190</volume>(<issue>16</issue>):<fpage>5690</fpage>-<lpage>5698</lpage>.</citation>
</ref>
<ref id="bibr23-0194599812442867">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Renelli</surname><given-names>M</given-names></name>
<name><surname>Matias</surname><given-names>V</given-names></name>
<name><surname>Lo</surname><given-names>RY</given-names></name>
<name><surname>Beveridge</surname><given-names>TJ</given-names></name>
</person-group>. <article-title>DNA-containing membrane vesicles of <italic>Pseudomonas aeruginosa</italic> PAO1 and their genetic transformation potential</article-title>. <source>Microbiology</source>. <year>2004</year>;<volume>150</volume>(<issue>7</issue>):<fpage>2161</fpage>-<lpage>2169</lpage>.</citation>
</ref>
<ref id="bibr24-0194599812442867">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>M</given-names></name>
<name><surname>Sasaki</surname><given-names>K</given-names></name>
<name><surname>Nakashimada</surname><given-names>Y</given-names></name>
<name><surname>Kakizono</surname><given-names>T</given-names></name>
<name><surname>Noparatnaraporn</surname><given-names>N</given-names></name>
<name><surname>Nishio</surname><given-names>N</given-names></name>
</person-group>. <article-title>Growth and flocculation of a marine photosynthetic bacterium <italic>Rhodovulum</italic> sp</article-title>. <source>Appl Microb Biotech</source>. <year>1998</year>;<volume>50</volume>(<issue>6</issue>):<fpage>682</fpage>-<lpage>691</lpage>.</citation>
</ref>
<ref id="bibr25-0194599812442867">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nemoto</surname><given-names>K</given-names></name>
<name><surname>Hirota</surname><given-names>K</given-names></name>
<name><surname>Murakami</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Effect of Varidase (streptodornase) on biofilm formed by</article-title> <source>Pseudomonas aeruginosa. Chemotherapy</source>. <year>2003</year>;<volume>49</volume>(<issue>3</issue>):<fpage>121</fpage>-<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr26-0194599812442867">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Silverman</surname><given-names>RJ</given-names></name>
<name><surname>Nobbs</surname><given-names>AH</given-names></name>
<name><surname>Vickerman</surname><given-names>MM</given-names></name>
<name><surname>Barbour</surname><given-names>ME</given-names></name>
<name><surname>Jenkinson</surname><given-names>HF</given-names></name>
</person-group>. <article-title>Interaction of <italic>Candida albicans</italic> cell wall Als3 protein with <italic>Streptococcus gordonii</italic> SspB adhesin promotes development of mixed-species communities</article-title>. <source>Infect Immun</source>. <year>2010</year>;<volume>78</volume>(<issue>11</issue>):<fpage>4644</fpage>-<lpage>4652</lpage>.</citation>
</ref>
<ref id="bibr27-0194599812442867">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodrigues</surname><given-names>L</given-names></name>
<name><surname>van der Mei</surname><given-names>HC</given-names></name>
<name><surname>Teixeira</surname><given-names>J</given-names></name>
<name><surname>Oliveira</surname><given-names>R</given-names></name>
</person-group>. <article-title>Influence of biosurfactants from probiotic bacteria on formation of biofilms on voice prostheses</article-title>. <source>Appl Environ Microb</source>. <year>2004</year>;<volume>70</volume>(<issue>7</issue>):<fpage>4408</fpage>-<lpage>4410</lpage>.</citation>
</ref>
<ref id="bibr28-0194599812442867">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ahimou</surname><given-names>F</given-names></name>
<name><surname>Jacques</surname><given-names>P</given-names></name>
<name><surname>Deleu</surname><given-names>M</given-names></name>
</person-group>. <article-title>Surfactin and iturin A effects on <italic>Bacillus subtilis</italic> surface hydrophobicity</article-title>. <source>Enzyme Microb Tech</source>. <year>2000</year>;<volume>27</volume>(<issue>10</issue>):<fpage>749</fpage>-<lpage>754</lpage>.</citation>
</ref>
<ref id="bibr29-0194599812442867">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kania</surname><given-names>RE</given-names></name>
<name><surname>Lamers</surname><given-names>GEM</given-names></name>
<name><surname>van de Laar</surname><given-names>N</given-names></name>
<etal/>
</person-group>. <article-title>Biofilms on tracheoesophageal voice prostheses: a confocal laser scanning microscopy demonstration of mixed bacterial and yeast biofilms</article-title>. <source>Biofouling</source>. <year>2010</year>;<volume>26</volume>(<issue>5</issue>):<fpage>519</fpage>-<lpage>526</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>